A US randomized questionnaire-based trial assessing the impact of the availability of inhaled insulin on therapeutic choice in patients with suboptimally controlled type 2 diabetes
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Antihyperglycaemics; Insulin; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Pfizer
- 25 Sep 2006 New trial record.